Evidence map›Paper›PMID 41489900›Full record

ArticleThe Journal of biological chemistry2025

Jade1 and the HBO1 histone acetyltransferase complex are spatial-selective cofactors of the pluripotency transcription factor Oct4.

Yifan Wu, Asit K Manna, Li Li, Zuolian Shen, Hiroshi Handa, Mahesh B Chandrasekharan, Dean Tantin

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yifan WuDepartment of Pathology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Asit K MannaDepartment of Pathology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Li LiHuntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, Utah, USA.
Zuolian ShenDepartment of Pathology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Hiroshi HandaCenter for Future Medical Research, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
Mahesh B ChandrasekharanHuntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Department of Radiation Oncology, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Dean TantinDepartment of Pathology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, School of Medicine, University of Utah, Salt Lake City, Utah, USA. Electronic address: dean.tantin@path.utah.edu.

Funding

Configuration-specific cofactors of Oct4R03TR004568 · NCATS · UNIVERSITY OF UTAH · PI TANTIN, DEAN · 2023 to 2023
$154k
NCATS NIH HHS R03 TR004568
6 · The paper itself

Abstract

Oct4 is a master regulator of pluripotency. Potential Oct4 interactors have been cataloged but the manner and significance of these interactions are incompletely defined. Oct4 is capable of binding to DNA in multiple configurations, however the relationship between these configurations and cofactor recruitment (and hence transcription output) are unknown. Here, we show that Oct4 interacts with common and unique proteins when bound to DNA in different configurations. A unique protein is Jade1, a component of HBO histone acetyltransferase complexes. Jade1 preferentially associates with Oct4 when bound to more palindromic Octamer-Related Element (MORE) DNA sequences that bind Oct4 dimers. Surprisingly, we find that the Oct4 N-terminal activation domain, rather than facilitating Jade1 binding, serves as an autoinhibitory domain that dampens the interaction. Chromatin immunoprecipitation and sequencing using HBO1, the enzymatic component of the complex, identifies a preference for binding adjacent to Oct4 at MORE sites. Using purified recombinant proteins and nucleosome complexes, we show that the HBO1 complex acetylates histone H3K9 within nucleosomes more efficiently when Oct4 is cobound to a MORE. An Oct4 mutant with superior MORE binding characteristics also shows superior ability to catalyze H3K9 acetylation. Jade1 knockdown reduces H3K9Ac at regions where Oct4 binds a MORE but not a simple octamer. Cryo-electron microscopy reveals that Oct4 bound to a MORE near the nucleosome entry/exit site partially unwinds DNA from nucleosome core particles, and identifies additional mass associated with the HBO1 complex. These results identify a novel mechanism of transcriptional regulation by Oct4.

Indexed as

Histone AcetyltransferasesOctamer Transcription Factor-3Pluripotent Stem CellsAcetylationDNAHumansNucleosomesProtein BindingDNAHistone AcetyltransferasesNucleosomesOctamer Transcription Factor-3POU5F1 protein, humanHBO1/KAT7/MYST2histone acetyltransferaseJade1Oct4 (Pou5f1)transcription factors

Identifiers

PMID41489900
PMCPMC12664036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.